LEI 506700GD96P247V99325
MMV MEDICINES FOR MALARIA VENTURE
Contract awards & public grants
SINGLE DOSE CURE OF FALCIPARUM MALARIA USING NEXT GENERATION COMBINATIONS → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2026-05-22
€18,750
Innovative Transformative CURE for MALaria: Rapid-Action Combinations to Replace Artemisinins → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2026-05-04
—
Optimizing the delivery and uptake of malaria vaccines in countries with areas of highly seasonal transmission in West and Central Africa → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2024-12-02
—
EU-Africa Research Infrastructure Alliance to Foster Infectious Disease research, Knowledge sharing and Innovation → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2024-10-04
—
SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2024-03-11
—
SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings] → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2023-03-07
—
European Screening Centre; Unique Library for Attractive Biology → MMV MEDICINES FOR MALARIA VENTURE
European Commission · CH · Grant · 2018-12-18
—
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.